Literature DB >> 14594345

The evolving role of nesiritide in advanced or decompensated heart failure.

Issam Zineh1, Richard S Schofield, Julie A Johnson.   

Abstract

Nesiritide is a recombinant form of human brain natriuretic peptide (BNP) that is structurally and biochemically identical to endogenously produced BNP. In humans, BNP is important in hemodynamic and neurohormonal equilibrium, helping to maintain adequate vascular volume and pressure in response to volume overload. The pharmacodynamic effects of nesiritide mimic the biologic effects of BNP. The molecular biology and actions of nesiritide and BNP are reviewed, with the therapeutic rationale for nesiritide in patients with acute or advanced decompensated heart failure highlighted. In addition, recommendations for its administration are provided, and unresolved therapeutic considerations are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594345     DOI: 10.1592/phco.23.12.1266.32705

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Nesiritide improves hemodynamics in children with dilated cardiomyopathy: a pilot study.

Authors:  Sarina K Behera; Jennifer C Zuccaro; Glenn T Wetzel; Juan C Alejos
Journal:  Pediatr Cardiol       Date:  2008-08-15       Impact factor: 1.655

2.  Nesiritide - A New Agent For Acute Decompensated Heart Failure.

Authors:  A G Mathur; J K Kairi; B B Nayak
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Brain natriuretic peptide and optimal management of heart failure.

Authors:  Nan Li; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.